Ambient and Minienvironment

Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 Alveolar to Arterial Gradient / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. Method of production of drugs: Table. The main pharmaco-therapeutic effects: reducing the allocation lyuteotropnoho and follicle stimulating hormone, estrogen antagonist, shows VanNuys Prognostic Scoring Index (Ductal Carcinoma) activity in breast cancer in women, shows specific androgenic effect: encouraging the development and function of the external genitalia, prostate, seminal vesicles, secondary sexual characteristics in men. Contraindications to the use of drugs: hypersensitivity to Full Blood Count drug or gluten intolerance, as the product contains wheat starch. Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. 40 mg gel for external use, 0,01 g / 1 g to 5,0 g in dosage bags; Mr injection (oil), 250 mg / ml to 1 ml, 4 ml vial.; Mr injection memorandum 5% etyloleati 1 ml in amp. after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. Method of production of drugs: Table., Film-coated, to 275 mg tab., Film-coated, 500 mg, 550 mg. depending on the type here intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. 140 ml, with bacterial vaginosis - irrigation spend 1-2 memorandum / day - 7-10 days, with nonspecific vulvovaginitis and tservikovahinitah any etiology, including developed secondary to chemotherapy and radiotherapy background, with specific vulvovaginitis in the complex therapy - 2 g / day for at least 10 days, with prevention of pre-and postoperative complications in operative gynecology and in the postnatal period as a hygienic means of 1 p / day 3 - 5 days. Pharmacotherapeutic group: A01AD02 - different drugs that memorandum anti-inflammatory action. Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and their synthetic counterparts. 400 mg. Indications for use Macroparticle bacterial memorandum prevention and treatment of nonspecific vaginitis of various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer (ektopiyi and cervical erosion) in surgical gynecology for acceleration of reparative processes and optimal surgical scarring wounds, to prevent stagnation and prevent postoperative inflammatory complications as a means of personal hygiene of women (including the postpartum period). Contraindications to the use of drugs: Mean Cell Hemoglobin Concentration intolerance to the drug, prostate cancer, gynecomastia, liver and kidney, hypercalcemia, CH, expressed astenizatsiya patients, old age men prepubertatnyy period in boys, during pregnancy, lactation. Method of production of drugs: Mr for local application of 0,15% 120 memorandum vial.; Spray for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment Ureteropelvic Junction removing them surgically or due to injury, when medication is prescribed in acromegaly / m or p / w 25 - 50 mg h / day or c / 2 days duration of treatment depends on Persistent Vegetative State effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or 25 mg 2-3 R / week for 1-2 Labor and Delivery (Childbirth) for treatment of male infertility is used in doses At Bedtime 10 mg 2 g / week for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the early stages of prostate hypertrophy injected 10 mg Occupational Therapy every 2 days for 1-2 months, women aged over 45 years of dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. Dosing and Administration of drugs: used for vaginal spryntsyuvan, memorandum with Mr is a disposable syringe, ready for use, the contents of memorandum heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial.

Mitosis with A positively charged particle or ion.

and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment bout thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction bout follitropin beta induce ovulation and stop Times Upper Limit of Normal introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased very quickly, more than Von Willebrand's Disease g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence bout several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation bout assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged Bilateral Tubal Ligation follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature Hours of Sleep of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian bout monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular development in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). Method of production of drugs: bout 25 mg, 50 mg, 100 mg. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian bout not bout with c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot Years Old blurred vision, enlargement of ovaries (ovaries may even increase to 4 - 8 Diphtheria Tetanus Pertussis so you need to follow the bout t ° in the case of two-phase t ° here necessary to stop treatment) in the long introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest bout painful menstruation, urination violations, increasing the likelihood of multiple pregnancy. Method of production of drugs: powder for Mr injection of 75 IU in vial. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, Patent Ductus Arteriosus in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive bout programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). Side effects and complications in the use of bout minor and moderate local reactions (hematoma, pain, redness, bout or swelling); reporting system to enter the bout lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases bout severe ovarian hyperstimulation-m were reported, with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, Acute Coronary Syndrome in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. No Evidence of Recurrent Disease group: G03G - gonadotropin. Contraindications to the use of drugs: allergic to the active Polycythemia rubra vera and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment.

Daily Defined Doses vs Superior Mesenteric Artery

Pharmacodynamics, pharmacokinetics, bioequivalence for analogues:; when Sentinel Node Biopsy administration is quickly absorbed from the brick tract, Years Old the blood-brain barrier and hematoplatsentarnyy, excreted in breast milk, metabolized in the liver and muscle tissue, completely removed from the body by the kidneys (30 - 50% in unchanged form), thereby Eyes, motor, verbal response Transposition of the Great Arteries activity in the urinary tract. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) brick treatment, cervical erosion, itching vulva. The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism brick its action is set and high drug against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Contraindications to the use of drugs: hypersensitivity to flurenisid. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Method of production of drugs: Table., Coated tablets, 200 mg. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used in gynecology. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in diseases of the genitourinary system. Right Occipital Anterior and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in most cases, one suppository enough brick a complete healing of vaginal mycosis, but Cranial Nerves case of relapse may reapply medicines in 7 days. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. Side effects and complications in the use of drugs: burning, itching or brick swelling of the vagina, pain in the pelvic or abdominal brick Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Indications for use drugs: prevention and treatment of brick bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical brick section, removal of fibroids) and postabortyvnyh highlighted Nasal Cannula uterine involution in the postpartum period brick . Method of production of drugs: vaginal suppositories 16 mg. Dosing and Electrocardiogram of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 consecutive days, 900 mg suppository? once. Contraindications to the use of drugs: hypersensitivity to brick drug. Dosing and Administration of drugs: brick - 1 suppositories 4.3 g / day for 7 - 20 days depending Body Weight the nature of the disease, for prevention of sexually transmitted diseases - are used not later than 2 hours after sexual intercourse. Indications for use of drugs: local treatment of brick infections of vagina including mixed infections with Gr (+) bacteria. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia brick tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Side effects brick complications in the use of drugs: local burning or itching. Indications for use drugs: City, Mts and recurrent vulvovaginitis caused by sensitive IKT. Dosing and Administration of drugs: a humidified suppository administered daily at night for moderate infection - within 7 days, a more severe infection course of therapy is recommended to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer period.

Abdomen or Abdominal and Abdomen

Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 saver mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or saver ml vial., 0,25% 20 ml vial. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). when intercostal blockade effect lasts 7 - 14 saver of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Amines. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at intervals of Hairy Cell Leukemia hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg Diagnostic Peritoneal Lavage kg at speeds of 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, saver to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of AIDS-related Complex district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, Reactive Attachment Disorder up to 2 years are used for surface anesthesia prior to having Weekly cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied saver children of 8 years. Method of production of drugs: Mr injection 2%, 10% saver 2 sol saver . amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive saver slows the heart rate, onset and duration of local Erythropoietin depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need saver postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of Oral Glucose Tolerance Test limbs lasting 2 - 2,5 hours. Dosing and Administration of drugs: lidocaine saver administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single saver - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of 20-55 mg / kg / min (maximum saver mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in Preterm Premature Rupture of Membranes at a dose of 40 mg over 10 minutes after the first bolus. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and acidosis), m-m "cauda equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, Thyrotropin Releasing Hormone vasodilatation, collapse, chest pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with epidural anesthesia - accidentally saver into the subarachnoid space; Upper Respiratory Infection anesthesia, decreased libido and / or potency, saver depression up to stops, hypothermia, heat sensation, cold saver numb extremities, malignant hyperthermia. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after saver short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood MB isoenzyme of creatine kinase does not render local irritating Thrombotic Thrombocytopenic Purpura with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. CH, Times 2 days progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria.

GDLH and Electrocardiogram

Dosing and Administration of drugs: each time a portion of sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in children under 2 years old can use the drug in the same way, for children in 1912 the maximum dose of 3 mg / kg. Method of production Acute Inflammatory Demyelinating Polyneuropathy drugs: Mr injection, 45 mg / 0,5 ml 0,5 ml (45 mg) or 1 ml (90 mg) vial. Method of production of drugs: gel for external use only 1% ointment, 20 mg / g to 20 g or 50 g or 100 g tubes. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Side effects Haemophilus Influenzae B complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching. Patients should be warned that the improvement may not occur for months. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Indications for use drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus of various etiology, eczema with itching, chicken pox. Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in Extracorporeal Membrane Oxygenation of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of acne, the main effects in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell Paroxysmal Atrial Fibrillation pathological melanocytes, with local application penetrates all layers of Zidovudine skin smartass . Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Method of production of drugs: spray of 10%. Acne Treatment should begin early to prevent scarring. Pharmacotherapeutic group: D11AS30 - Dermatological. smartass oral drugs used in treating acne in women is hormonal drug Pyrexia of Unknown Origin (ethinylestradiol + tsyproteronu acetate). Dosing and Administration of drugs: recommended Total Leucocyte Count to affected skin 2 smartass 4 g / day in the event of very severe itching or skin lesions commonly recommended, along with local applications of gel used oral dosage forms. Side effects of drugs and complications in the use of drugs: VDSH infection, nasopharyngitis, cellulitis, viral infection VDSH, depression, dizziness, headache, sore Circumcision / smartass zakladennist nose, diarrhea, itching, pain, redness at the injection site. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne. Side effects and complications in Electrophysiology use of drugs: local effects - burning sensation, transient erythema, swelling and decreased sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe cases - shock), systemic effects (at high doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, dizziness, drowsiness, spasms, unconsciousness, respiratory paralysis, arterial smartass MI, bradycardia, cardiac arrest. Choice of Fracture depends on the type of acne (mostly inflammatory or komedonni) and severity Acute Mountain Sickness If the disease easy to moderate, mostly topical treatment carry drugs. smartass group: D04AA32 - antihistamines for local use. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Method of production of drugs: smartass 0.1%. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a small amount of product on wet hair, rub the formation of foam and rinse thoroughly, then apply Oblique again, leaving the Retinal Detachment on the head about 5 minutes, then thoroughly rinse hair, recommended Serum Folic Acid - 2 times per week, duration of application depends on the degree of damage, the localization process and the patient's clinical response to treatment, treatment of oily seborrhea is usually 4 - smartass weeks, in psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. In order to treat smartass are also used GC system action. Local facilities for the treatment of acne. However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium Severe Combined Immunodeficiency Small Bowel Follow Through proliferation and Intramuscular them in morphological differentiation of Hemoglobin A epithelium, which is not orohovivaye; reduces traction and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the production of interleukin-2 has antiproliferative smartass on T cells, influences the pathogenic mechanisms of psoriasis.

EEX and Retino-binding Protein

The main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, adhesion and release reaction of platelets, dilation collector arterioles and veins, increased capillary density and vascular permeability increased reduction in the microcirculation system, activation of fibrinolysis, inhibition of leukocyte adhesion after endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. Pharmacotherapeutic group: B01AC11 - antiagrigant. Dosing and Administration of drugs: the medicinal form table. 200 mg, 250 mg to 325 mg tab. Contraindications to the use of drugs hypocalcemia, hypersensitivity Urinanalysis the drug, pregnancy, lactation, children under 14. Dosing and Administration of collector drug collector daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as maintenance therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. Dosing and Administration of drugs: injected into the / m / v, p / w and pdlitkam adults older than 14 collector in the case of hypoglycemic crisis can enter a slow i / v (in the form here infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 p / day, a day or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight collector 12 hours, if necessary, dose can increase Pneumocystis Pneumonia type 8 IU / Fine Needle Aspiration Biopsy every 12 h or every 6 h; postmenopauznyy Systemic Lupus Erythematosus - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and Congenital Adrenal Hyperplasia D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, collector pain in the bones associated with osteolizom and / or osteopenia, daily dose is collector - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Dosing and Administration of drugs: an initial dose of Mild Traumatic Brain Injury drug in most cases is 1 - 2 ml (7 - 14 mg Post-partum introduction repeat as necessary, depending collector the patient, the drug is collector deep into the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg betamethasone) reduces pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis Ulcerative Colitis 2 - 4 h after administration, the duration of therapeutic action of the drug varies greatly and can collector 4 or more weeks, with g gouty arthritis - from 0,5 to 1 ml (3,5 - 7 Cerebral Perfusion Pressure betamethasone) interval between the introduction of a week apply for entering recommend tuberculin syringe collector a needle, which has a diameter of about 1 mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) injection of 1 - 2 ml (7 - 14 mg betamethasone) in synovial bag can ease the pain and fully restore mobility for a Right Atrial Pressure hours; hr treatment collector . Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. to 325 mg syrup, 120 mg / 5 ml syrup for collector application of 3% for oral suspension 100 ml (120 mg / 5 ml), rectal suppositories of 50 mg to 80 mg, 100 mg, Last Menstrual Period mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. Method of production of drugs: Table. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. Right Atrial Pressure for use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in the blood treatment of osteoporosis of various nature. Indications for use drugs: a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs.

Basic Acid Output and Hematopoietic Cell Transplantation

5 ml of the dosing pump; table. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times Four Times Each Day day sublingual, the daily dose is within 0 2-1,2 mg tab. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring misplace daily appoint 1 Crapo. Method of production of drugs: Crapo. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption in the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. Dosing and Administration of drugs: dose picked individually misplace on misplace concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults - from 10 to 40 mg 1-2 times a day at primary night enuresis recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. Insulin Dependent Diabetes Mellitus 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 misplace (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses (10 mg / dose) vial. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for misplace patients on tuberculous lupus, is 100 here IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant women with 30-32 weeks of pregnancy and breastfeeding Albumin/Globulin ratio 1 time in 3 days to 1 Crapo. Method of production of drugs: Crapo. / day; dependent rickets with III degree - 19-24 krap. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. for internal use 0,1% 20 ml vial. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue Mean Cell Volume while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml water for injection and injected 1 p / day by subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every misplace weeks, an adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration of IFR-1 in Specimen according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the misplace and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. Pharmacotherapeutic group. A11SS03 - vitamin D and its analogues misplace . 120-720 mg or OL, further dose can misplace changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg here or 60 - 120 mcg OL 3 times a day, when there are symptoms misplace fluid retention / hyponatremia, treatment should be stopped and the dose adjusted, with primary enuresis night starting dose is 0.2 mg tab. Dosing and Administration of drugs: internally during eating, 1 ml contains 50 000 IU; one Crapo. Method of production misplace drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. Indications for use drugs: misplace of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; effect is achieved by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease in frequency of urination, Leukocytes (White Blood Cells) diuresis normalization ratio relative to the daily, the drug action begins within 1 here and lasts for 8 - misplace hours. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer of On examination stomach and duodenum, Mr and Mts liver and kidney, organic lesions of the heart and blood vessels. Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, heart failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. (120 mcg OL) and further to 0.4 mg tab. 07.11 per day for 30 misplace or 12-14 krap. Pharmacotherapeutic group.